Plazomicin Is Active Against Metallo-β-Lactamase-Producing Enterobacteriaceae

Plazomicin is an aminoglycoside that was approved in June 2018 by the US Food and Drug Administration for the treatment of complicated urinary tract infections, including pyelonephritis, due to Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, and Proteus mirabilis. Plazomicin was engin...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Open Forum Infect Dis
Hlavní autoři: Serio, Alisa W, Keepers, Tiffany, Krause, Kevin M
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2019
Témata:
Brief Reports
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6446133/
https://ncbi.nlm.nih.gov/pubmed/30968059
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz123
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky